Modern Mobility Aids Inc Provides Update to Shareholders
ACCESSWIREMarch 4, 2020, 6:55 PM EST
TORONTO, ONTARIO / ACCESSWIRE / March 4, 2020 / Modern Mobility Aids Inc. (‘the Company") (MDRM) announced today that it started the process to bring the company's filings with OTC Markets and the NVSOS up to date. The company expects to have a further update for its shareholders in the next few days
While every effort will be made to report on a much more regular basis, much of the information at this stage is protected by non-disclosure agreements. We can state that the Company is in the final stages of entering into a co-development agreement with a DNA diagnostic product for rapid diagnostics of infectious diseases.
Over and above that matter, MDRM management will communicate to shareholders on a regular basis. We will endeavor to keep our loyal shareholders up to date and current to the extent we are able to do so and appreciate your ongoing loyalty and support throughout this process.
SCROLL TO CONTINUE WITH CONTENTAd
There will be some additional updates regarding the management team and board in the days ahead.
For more information please contact:
Modern Mobility Aids Inc.
Tito Di Marco, President
Email: tdimarco@mdrminc.com
647 783 2195
Safe Harbor
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). In particular, when used in the preceding discussion, the words "pleased," "believe," "expects," "reflects," "aligned," "anticipates," "planned" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any initiatives will result in what the Company had originally intended. Any investment made into Galileo Life Sciences, Inc., would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the Company's financial reports and filings.
Story continues
Start the conversation
Sign in to post a message.
What to Read Next
Stock market news live: Stocks, yields drop on new coronavirus fears; NY says 11 new cases discovered
Yahoo Finance
Bill Murray Is the Richest Team Owners in Sports
90MINAd
Gen X denied a mortgage more than any other generation, study shows
Yahoo Finance
Market Recap: Thursday, March 5
Yahoo Finance Video
There's 'no historical precedent' for working from home amid coronavirus fears
Yahoo Finance
25 Dying Professions You Should Avoid
Work + MoneyAd
Coronavirus outbreak may have unleashed panic buying of Hostess Twinkies and Ding Dongs
Yahoo Finance
Art Van Furniture liquidating: Midwest retailer to close all stores
USA TODAY
HP CEO: Xerox's offer will have to address these 3 things
Yahoo Finance
The Toughest Hockey Players Who Ever Lived
Stadium TalkAd
Baker Boyer CIO on the economic implications of the coronavirus
Yahoo Finance Video
Voters don’t want the Sanders-Warren revolution
Yahoo Finance
Billionaire Sam Zell says he’s buying at ‘ridiculously low’ prices in one particular sector amid market volatility
MarketWatch
Ranking the Most Dangerous Countries To Visit
Far & WideAd
Innovation Minister targets Big Three mid-range cellphone plans with 25 per cent cut over two years
Yahoo Finance Canada
Oscar-winning writer argues why all Americans should care about prison reform
Yahoo Finance
Bernstein cuts airliner targets
Yahoo Finance Video
8 Assets You Won't Lose During Bankruptcy
Debt.caAd
